We also show two examples of intron retention events in controls instead of exon skipping in FSHD patients in two highly important sarcomeric genes, skeletal muscle troponin 3 (TNNT3) and tropomyosin 1 (TPM1). This evidence concerns the gene TNNT3 and facioscapulohumeral muscular dystrophy.